The impact of hormone receptor on the clinical outcomes of HER2-positive breast cancer: a population-based study.
Yiqun HanYun WuHangcheng XuJiayu WangBing-He XuPublished in: International journal of clinical oncology (2022)
This study revealed profound heterogeneity associated with HR status in the clinical outcomes of HER2-positive breast cancer regarding clinicopathological features, metastatic patterns, and prognosis. Prospective studies to optimize therapeutic strategies for HER2-positive subgroups are warranted.